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ostnatal arteriogenesis is the expansion of existing collateral vessels secondary to mechanical stress or chemical stimuli and is recognized to be important for vascular reperfusion after ischemic injury. 1 During the initial vasodilatory phase, obstruction of the main artery causes increased blood flow through collateral vessels, via nitric oxide (NO)-dependent vasodilation. 2 Notch signaling has been shown to play a critical role in postnatal arteriogenesis, but the mechanism of its action is not completely defined. 3 Recently, we have shown that Notch activation induces NO synthesis through the release of a paracrine factor that results in phosphorylation and activation of endothelial NO synthase (eNOS). 4 In this study, we examined the effect of endothelial cell (EC)-Notch inhibition on postischemic vasodilation using a conditional mouse model, where the pan-Notch inhibitor, dominant negative Mastermind-like 1 (dnMAML), is expressed under the control of a vascular endothelial (VE)-cadherin promoter. We demonstrate that postnatal EC-Notch inhibition results in a significant decrease in basal NO in large vessels. EC-Notch inhibition blocks reperfusion of ischemic tissue because of attenuation of NO release after ischemia. These findings suggest that Notch activation is required for the initial vasodilatory phase in response to ischemia.
Materials and Methods

Animals and Hind Limb Ischemia Model
All protocols were approved by the Committee on Animal Care Committee of the University of British Columbia (Vancouver, British Columbia). The tetracycline operator site (Tet OS )-dnMAML1-green fluorescent protein (GFP) (dnMAML) transgenic mouse was generated as previously described. 4 VE-cadherin-tTA (VEtTA) mice were a kind gift of L. Benjamin, Harvard Medical School (Boston, MA). 5 Endothelial Notch inhibition was achieved as previously described. 4 All of the animals were provided with doxycycline (50 μg/mL) in the drinking water to suppress dnMAML-GFP expression until 6 weeks of age. Animals were subjected to 2 weeks of Notch inhibition, followed by measurement of mean arterial pressure, 6 myograph recording, 6 or femoral ligation 3 procedures, as previously described. For femoral ligation, mice were anesthetized under isofluorane, and from the inguinal ligament the artery was ligated distal to the third arterial branch and proximal to the fourth, the latter being just proximal to a major vessel bifurcation. This model produces less severe ischemia than standard models, as previously shown. 3 Littermates were used as controls. Blood flow was monitored by laser Doppler perfusion imaging (PeriScan PIM II, Perimed, Las Vegas, NV) preligation and postligation. The extent of reperfusion was calculated by taking the perfusion ratio of the ischemic leg over the nonischemic leg using LDPI 2.6 (Perimed; Las Vegas, NV). See the online-only Data Supplemental Methods for reagents and tissue isolation.
Objective-We have recently described that Notch activates nitric oxide (NO) signaling in the embryonic endocardium. Both Notch signaling and NO signaling have been shown to be important during adult arteriogenesis. Notch has been shown to be required for remodeling of the collateral vessels, whereas NO is required for the initial vasodilatory response to ischemia. Whether Notch also has an impact on the vasodilatory phase of arteriogenesis after ischemia is not known. We tested the hypothesis that endothelial cell-Notch function is required for NO induction and vasodilation, in response to ischemia in the adult vasculature. Methods and Results-We observed a significant decrease in NO levels in the dorsal aorta using a mouse model where Notch was inhibited in endothelial cell in a Tet-inducible fashion. In a femoral artery ligation model, inhibition of endothelial cell-Notch reduced reperfusion and NO generation, as quantified by laser Doppler perfusion imaging and by phosphoendothelial NO synthase, nitrotyrosine, and phosphovasodilator-stimulated phosphoprotein staining, respectively. 
Conclusion-Endothelial
Results and Discussion
EC-Notch Inhibition Does Not Affect Basal Vascular Function
We have previously identified a novel link between Notch and the NO pathway. 4 As targeted deletion of Notch1 results in embryonic death, 7 to determine the role of Notch in the maintenance of blood pressure in the adult, we conditionally inhibited Notch signaling in the endothelium starting at 6 weeks of age using VEtTA-Tet OS -dnMAML mice. 4 We did not detect a difference in mean arterial pressure between VEtTA-Tet OS -dnMAML and littermate controls (data not shown) suggesting that Notch activation is not critical for basal vascular homeostasis.
Endothelial Notch Activation Is Required for Vasodilation Postischemia
Previous work has shown that shear stress, through vascular endothelial growth factor induction, activates Notch in EC. 8, 9 To evaluate the effect of endothelial Notch inhibition in response to ischemia-related vasodilation, we subjected VEtTA-Tet OS -dnMAML and littermate control mice to hind limb ischemia (HLI) using a selective femoral artery ligation model. 3 Relative blood flow measurements by laser Doppler imaging revealed comparable perfusion in both VEtTA-Tet OS -dnMAML and littermate controls before surgery ( Figure 1A and 1B) . Serial readings in littermate controls revealed rapid reperfusion in the ischemic leg immediately after and at 1-and 2-days post-HLI ( Figure 1B) . However, reperfusion was blunted in VEtTATet OS -dnMAML animals post-HLI ( Figure 1B) . To confirm that EC-expression of dnMAML-GFP blocked downstream Notch activation, we stained for GFP to detect dnMAML expression, Notch intracellular domain, and the Notch downstream target Hey2 in the ischemic collaterals after 1 day. We observed colocalization of GFP staining with CD31 expression in the VEtTA-Tet OS -dnMAML animals, confirming the expression of the dnMAML-GFP transgene specifically in the endothelium ( Figure 1C ). Notch cleavage was present in both VEtTA-Tet OS -dnMAML and littermate controls as expected and evidenced by presence of the Notch intracellular domain form ( Figure  1C ). However, Notch activity-as determined by upregulation of the target Hey2-was absent in VEtTA-Tet OS -dnMAML animals, indicating that Notch signaling was blocked ( Figure  1C ). These findings suggest that Notch inhibition perturbs the initial vasodilatory phase that occurs consequent to ischemia.
Endothelial Notch Activation Is Required for NO Generation and Signaling Postischemia
To understand the effect of EC-Notch inhibition on reperfusion in the HLI model, we examined the level of NO and vascular function of thoracic dorsal aortas of the animals. There were significantly lower levels of NO in VEtTA-Tet OS -dnMAML aortas compared with littermate controls (Figure 2A) . However, we did not observe defects in NO-dependent vasodilation secondary to acetylcholine stimulation ( Figure IA in the online-only Data Supplement). Further, vascular contraction in response to phenylepherine was not altered indicating that Notch blockade permits normal levels of endothelial-derived NO production through an independent mechanism (Figure IB in the online-only Data Supplement). These results suggest that although EC-Notch inhibition decreases basal NO levels, compensatory mechanisms exist to maintain vascular homeostasis in the unperturbed stated.
We next examined the collateral arteries to determine whether there was a difference in vascular smooth muscle cell coverage of the vessels at 1-and 2-days after HLI ( Figure II Figure 2C ), suggesting that NO production occurs secondary to ischemia, and that Notch signaling is required for NO induction in this stressed state. To demonstrate downstream activation of the NO pathway, phosphorylation of vasodilator-stimulated phosphoprotein was examined. 10 Phosphovasodilator-stimulated phosphoprotein-Ser157 staining in ischemic collaterals was significantly higher in littermate controls than VEtTA-Tet OS -dnMAML animals and was localized to the EC ( Figure 2D and Figure IIIC in the online-only Data Supplement). This difference in phosphovasodilator-stimulated phosphoproteinSer157 was not observed in the nonischemic vessels of the contralateral limb, consistent with NO signaling occurring secondary to ischemia-induced Notch signaling ( Figure 2D ).
Heterozygous loss of Notch1 or the Notch ligand Dll1 results in defective arteriogenesis after femoral ligation. 11, 12 In both models, revascularization of the ischemic leg was blunted in animals with attenuated Notch activation. Our current studies suggest that immediately after ischemia, activated Notch induces EC NO production, which initiates reperfusion through vasodilation. 4, 7 Over the longer term, remodeling of the vessel results in a permanent expansion of the collateral. We have previously shown that Notch is also important in the remodeling phase, but secondary to activation in a smooth muscle cell precursor rather than in EC. 3 Thus, Notch activation appears to play a role in reperfusion after ischemia, both in the immediate vasodilatory response as well as in longer term remodeling. Our findings suggest that inhibition of EC-Notch decreases eNOS activation and NO production in these animals, and when challenged with ischemia, EC-Notch inhibited animals fail to generate a vasodilatory response. -dominant negative Mastermind-like (dnMAML) and littermate control aortas were measured using the Griess reaction. Results are normalized to either total protein (μg) or total protein relative to body weight (g) and expressed as the mean±SE Immunofluorescence quantification for endothelial NO synthase (eNOS) activation (B, phosphoeNOS) was achieved by normalizing the number of positively stained pixels to endothelium (CD31). Immunofluorescence quantification for NO (C, nitrotyrosine) and downstream target phosphovasodilator-stimulated phosphoprotein-Ser157 (D) was achieved by normalizing the number of positively stained pixels to cell count (DAPI) and are plotted as box-and-whisker plots.
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